Advertisement
Screener

ARVINAS, INC. (ARVN) Capital Expenditures Incurred but Not yet Paid

2.3 / 5 stars · 35/75 Roast Me

ARVINAS, INC. Capital Expenditures Incurred but Not yet Paid

ARVINAS, INC. (ARVN) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-11

  • ARVINAS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $100.00K.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $300.00K, a 66.67% decline from fiscal 2024.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $900.00K.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • ARVINAS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $100.00K, a 80.00% decline from fiscal 2021.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 3 month as first filedCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 6 month as first filedCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 9 month as first filedCapital Expenditures Incurred but Not yet Paid 12 monthCapital Expenditures Incurred but Not yet Paid 12 month as first filed
2026-03-31$0.00
10-Q · filed 2026-05-11
2025-12-31$300.00K
10-K · filed 2026-02-24
2025-03-31$100.00K
10-Q · filed 2026-05-11
2024-12-31$900.00K
10-K · filed 2026-02-24
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$0.00
10-Q · filed 2024-07-30
$0.00
derived: sum of 3 quarters · filed 2026-02-24
-$400.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$0.00
10-Q · filed 2025-05-01
$0.00
derived: sum of 2 quarters · filed 2026-02-24
-$400.00K
derived: sum of 3 quarters · filed 2026-02-24
-$100.00K
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$400.00K
derived: sum of 2 quarters · filed 2026-02-24
-$100.00K
derived: sum of 3 quarters · filed 2026-02-24
$0.00
10-K · filed 2026-02-24
2023-09-30-$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$100.00K
derived: sum of 2 quarters · filed 2024-07-30
$0.00
10-Q · filed 2023-11-07
-$200.00K
derived: sum of 4 quarters · filed 2025-02-11
2023-06-30$300.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$400.00K
10-Q · filed 2024-07-30
$200.00K
derived: sum of 3 quarters · filed 2025-02-11
$0.00
derived: sum of 4 quarters · filed 2025-02-11
2023-03-31$100.00K
10-Q · filed 2024-05-07
-$100.00K
derived: sum of 2 quarters · filed 2025-02-11
-$300.00K
derived: sum of 3 quarters · filed 2025-02-11
$100.00K
derived: sum of 4 quarters · filed 2025-02-11
2022-12-31-$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
-$400.00K
derived: sum of 2 quarters · filed 2025-02-11
$0.00
derived: sum of 3 quarters · filed 2025-02-11
$100.00K
10-K · filed 2025-02-11
2022-09-30-$200.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$200.00K
derived: sum of 2 quarters · filed 2023-11-07
$300.00K
10-Q · filed 2023-11-07
$700.00K
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$500.00K
10-Q · filed 2023-08-08
$900.00K
derived: sum of 3 quarters · filed 2024-02-27
$700.00K
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$100.00K
10-Q · filed 2023-05-05
$500.00K
derived: sum of 2 quarters · filed 2024-02-27
$300.00K
derived: sum of 3 quarters · filed 2024-02-27
$500.00K
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$200.00K
derived: sum of 2 quarters · filed 2024-02-27
$400.00K
derived: sum of 3 quarters · filed 2024-02-27
$500.00K
10-K · filed 2024-02-27
2021-09-30-$200.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$100.00K
10-Q · filed 2022-11-09
$75.53K
10-Q · filed 2021-11-03
-$177.94K
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$300.00K
10-Q · filed 2022-08-04
$296.43K
10-Q · filed 2021-08-05
$22.06K
derived: sum of 3 quarters · filed 2023-02-23
$647.52K
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$100.00K
10-Q · filed 2022-05-05
$108.92K
10-Q · filed 2021-05-04
-$177.94K
derived: sum of 2 quarters · filed 2023-02-23
$447.52K
derived: sum of 3 quarters · filed 2023-02-23
$224.40K
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$277.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$347.52K
derived: sum of 2 quarters · filed 2023-02-23
$124.40K
derived: sum of 3 quarters · filed 2023-02-23
$500.00K
10-K · filed 2023-02-23
$522.71K
10-K · filed 2021-03-01
2020-09-30$625.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$402.34K
derived: sum of 2 quarters · filed 2021-11-03
$777.94K
10-Q · filed 2021-11-03
$839.34K
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$223.13K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$152.48K
10-Q · filed 2021-08-05
$213.88K
derived: sum of 3 quarters · filed 2022-02-28
$279.73K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$375.60K
10-Q · filed 2021-05-04
$437.00K
derived: sum of 2 quarters · filed 2022-02-28
$502.86K
derived: sum of 3 quarters · filed 2022-02-28
$65.64K
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$61.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$127.26K
derived: sum of 2 quarters · filed 2022-02-28
-$309.97K
derived: sum of 3 quarters · filed 2022-02-28
$200.00K
10-K · filed 2022-02-28
$189.91K
10-K · filed 2020-03-16
2019-09-30$65.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$371.37K
derived: sum of 2 quarters · filed 2020-11-05
$138.60K
10-Q · filed 2020-11-05
-$24.21K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$437.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$72.74K
10-Q · filed 2020-08-04
-$90.06K
derived: sum of 3 quarters · filed 2021-03-01
$232.24K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$509.97K
10-Q · filed 2020-04-28
$347.16K
derived: sum of 2 quarters · filed 2021-03-01
$669.46K
derived: sum of 3 quarters · filed 2021-03-01
$669.46K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$162.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$159.49K
derived: sum of 2 quarters · filed 2021-03-01
$159.49K
derived: sum of 3 quarters · filed 2021-03-01
$159.49K
10-K · filed 2021-03-01
2018-09-30$322.30K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
$322.30K
derived: sum of 2 quarters · filed 2019-11-04
$322.30K
10-Q · filed 2019-11-04
$322.30K
derived: sum of 4 quarters · filed 2019-11-04
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
$0.00
10-Q · filed 2019-08-05
$0.00
derived: sum of 3 quarters · filed 2019-08-05
2018-03-31$0.00
10-Q · filed 2019-05-09
$0.00
derived: sum of 2 quarters · filed 2019-05-09
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$0.00
10-K · filed 2019-03-26
2017-09-30$0.00
10-Q · filed 2018-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Evolus, Inc. (EOLS)United States$0.519B-13.32
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85